Nearly 75% of Kids Surveyed in Singapore Are Still Not Washing Their Hands Correctly
Three years since COVID-19 began, survey reveals that one-quarter of kids do not wash their hands after using the bathroom 56% don't use soap every time they wash their hands 72% do not comply with guidelines recommending they wash their hands for 20 to 30 seconds SINGAPORE, Oct. 12,...
WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody
SHANGHAI, Oct. 11, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), and Toregem BioPharma, a biotech startup company from Kyoto University, today announced that they have signed a Memorandum of Understanding (MOU) to form a strategic partnership in the development of TRG035, a monoclonal antibody targeting USAG-1 for the treatment...
TVM Capital Healthcare and Siemens Healthineers announce strategic collaboration to advance healthcare access in Southeast Asia
The alliance aims to combine forces of healthcare specialist investor TVM Capital Healthcare and leading Medtech company Siemens Healthineers, to ensure patients' improved access to quality and affordable healthcare services and accelerate sustainable growth for healthcare providers across Southeast Asia. SINGAPORE, Oct. 12, 2022 /PRNewswire/ -- TVM Capital Healthcare, an emerging-markets focused healthcare private equity firm headquartered in Singapore and Dubai,...
Ascend continues broad expansion into new markets, launches HiDura™ MED portfolio
HOUSTON, Oct. 12, 2022 /PRNewswire/ -- Ascend Performance Materials today announced a new portfolio of medical grade nylon 6,6 resins and engineered materials for the healthcare market under its HiDura™ brand. HiDura MED polyamides by Ascend Performance Materials can be used in medical durables, drug delivery, surgical instruments, medical equipment...
CSafe and BioLife Solutions, Inc. announce partnership to expand supply chain solutions for the cell and gene therapy market
CSafe joins BioLife's global partner network of cold chain solution providers using the evo® cold chain management platform MONROE, Ohio and BOTHELL, Wash., Oct. 11, 2022 /PRNewswire/ -- CSafe, one of the largest active and passive temperature-controlled shipping solutions providers for pharmaceuticals, and BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of...
Great Bay Bio Announces Official Launch of Site-Specific Integration Platform for Cell Line Development, AlfaCell®
HONG KONG, Oct. 11, 2022 /PRNewswire/ -- Great Bay Bio (hereinafter referred to as "GBB") today announces the official launch of its self-developed AI-enabled site-specific integration platform for cell line development (CLD), AlfaCell®. AlfaCell® platform has pioneered to integrate GBB's proprietary AI technologies with cell line development techniques, which is a milestone in the AI-enabled bioprocessing development. ...
Samsung Biologics unlocks additional capacity for production at its newest Plant 4
Plant 4 commences GMP operations within just 23 months since groundbreaking, as planned Partial operations add fresh biomanufacturing capacity of 60,000 liters Plant 4's total capacity of 240,000 liters to be ready early next year INCHEON, South Korea, Oct. 11, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), announced today that...
HanAll’s Licensed Partner in China Enters Sublicense Agreement with CSPC to Further Accelerate Development of Batoclimab
Harbour BioMed, HanAll's licensed partner in China, signed a sublicense agreement with CSPC NBP Pharmaceutical for batoclimab, an FcRn compound originally discovered and developed by HanAll Biopharma Batoclimab is one of the most advanced FcRn inhibitors being developed in Greater China, with the potential of becoming the first-in-FcRn class therapy to...
IASO Biotherapeutics and Cabaletta Bio Announce Exclusive Worldwide License Agreement for Clinically Validated CD19 Binder
PHILADELPHIA and SAN JOSE, Calif. and NANJING and SHANGHAI, China, Oct. 11, 2022 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative medicines and Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced...
Integrating Fitbit & MindFi App into Daily Lifestyle Leads to Significant Improvements in Teachers’ Mental Wellness – Singapore Study
SINGAPORE, Oct. 11, 2022 /PRNewswire/ -- Regular use of a mental wellness app solution combined with Fitbit wearable devices to track activity and sleep can have a positive impact on users' physical and mental health, according to a new pilot study involving Singapore teachers. After a challenging time for teachers which saw working...
